U.S. markets closed

Cytek Biosciences, Inc. (CTKB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.93-0.35 (-1.44%)
At close: 4:00PM EDT
23.93 0.00 (0.00%)
After hours: 04:00PM EDT

Cytek Biosciences, Inc.

46107 Landing Parkway
Fremont, CA 94538
United States
877 922 9835

IndustryMedical Devices
Full Time Employees429

Key Executives

NameTitlePayExercisedYear Born
Dr. Wenbin Jiang Ph.D.Pres, CEO & Director353.12kN/A1964
Mr. Patrik Sebastian JeanmonodChief Financial Officer340.11kN/A1966
Dr. Ming Yan Ph.D.CTO & Director340.53kN/A1963
Dr. Allen B. Poirson Ph.D.Sr. VP of Marketing & Corp. Devel.N/AN/A1960
Mr. Melik UlusuVP of Operations & Integrated Supply ChainN/AN/AN/A
Mr. Mark EdingerVP of Scientific AffairsN/AN/AN/A
Ms. Valerie T. Barnett J.D.Gen. Counsel & Corp. Sec.N/AN/A1975
Mr. Raymond A. LanniganVP of Global Sales & ServiceN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cytek Biosciences, Inc. engages in the manufacture and sale of cell analysis solutions for clinical and biomedical research in the fields of drug discovery, genomics, immuno-oncology, immuno-profiling, infectious diseases, inflammatory diseases, and multi-site standardization applications. Its instruments include the Aurora and Northern Lights systems, which are flow cytometers to deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also offers cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. Its customers include pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. Cytek Biosciences, Inc. was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. The company was incorporated in 2014 and is headquartered in Fremont, California.

Corporate Governance

Cytek Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.